In the past week, ALT stock has gone up by 12.19%, with a monthly gain of 58.04% and a quarterly plunge of -16.06%. The volatility ratio for the week is 9.71%, and the volatility levels for the last 30 days are 7.96% for Altimmune Inc The simple moving average for the last 20 days is 16.58% for ALT’s stock, with a simple moving average of -12.48% for the last 200 days.
Is It Worth Investing in Altimmune Inc (NASDAQ: ALT) Right Now?
The stock has a 36-month beta value of 0.60. Opinions on the stock are mixed, with 5 analysts rating it as a “buy,” 3 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for ALT is 76.21M, and at present, short sellers hold a 29.45% of that float. On May 09, 2025, the average trading volume of ALT was 2.57M shares.
ALT) stock’s latest price update
Altimmune Inc (NASDAQ: ALT)’s stock price has soared by 8.21 in relation to previous closing price of 5.36. Nevertheless, the company has seen a gain of 12.19% in its stock price over the last five trading days. globenewswire.com reported 2025-05-08 that MASH Resolution Index (MASHResInd) model highly predictive of MASH resolution MASH Resolution Index (MASHResInd) model highly predictive of MASH resolution
Analysts’ Opinion of ALT
Stifel, on the other hand, stated in their research note that they expect to see ALT reach a price target of $18. The rating they have provided for ALT stocks is “Buy” according to the report published on January 08th, 2025.
UBS gave a rating of “Buy” to ALT, setting the target price at $26 in the report published on November 12th of the previous year.
ALT Trading at 10.99% from the 50-Day Moving Average
After a stumble in the market that brought ALT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -48.03% of loss for the given period.
Volatility was left at 7.96%, however, over the last 30 days, the volatility rate increased by 9.71%, as shares surge +37.12% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -2.36% lower at present.
During the last 5 trading sessions, ALT rose by +12.19%, which changed the moving average for the period of 200-days by -8.95% in comparison to the 20-day moving average, which settled at $4.97. In addition, Altimmune Inc saw -19.56% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ALT starting from Sohn Catherine A., who purchase 1,000 shares at the price of $5.78 back on Mar 17 ’25. After this action, Sohn Catherine A. now owns 1,000 shares of Altimmune Inc, valued at $5,784 using the latest closing price.
WEAVER GREGORY L, the Chief Financial Officer of Altimmune Inc, purchase 10,000 shares at $5.20 during a trade that took place back on Mar 13 ’25, which means that WEAVER GREGORY L is holding 10,000 shares at $51,996 based on the most recent closing price.
Stock Fundamentals for ALT
Current profitability levels for the company are sitting at:
- -5158.6 for the present operating margin
- -9.05 for the gross margin
The net margin for Altimmune Inc stands at -4752.95. The total capital return value is set at -0.8. Equity return is now at value -59.86, with -54.33 for asset returns.
Based on Altimmune Inc (ALT), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -47.5. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is -11463.56.
Currently, EBITDA for the company is -94.81 million with net debt to EBITDA at 0.37. When we switch over and look at the enterprise to sales, we see a ratio of 20571.72. The receivables turnover for the company is 0.01for trailing twelve months and the total asset turnover is 0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 13.10.
Conclusion
To sum up, Altimmune Inc (ALT) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
